Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Hydrogel scaffolds can help wounds heal better and grow hair.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Targeting TGFβ can improve skin immunity in older people.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Fat cells are important for tissue repair and stem cell support in various body parts.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

Targeted immunotherapy could be a promising new treatment for hair regrowth.